{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:19:48Z","timestamp":1789654788698,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Instituto Nacional de Salud"},{"name":"PROVAC Initiative of the Pan American Health Organization"},{"name":"National Council of Science, Technology and Technological Innovation of Peru"},{"name":"International Clinical Epidemiology Network"},{"name":"Ministry of Health of Peru"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2014.12.039","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:01:20Z","timestamp":1429747280000},"page":"A154-A166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru"],"prefix":"10.1016","volume":"33","author":[{"given":"Edward","family":"Mezones-Holguin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Canelo-Aybar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara Bess","family":"Janusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Ja\u00faregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seimer","family":"Escobedo-Palza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denhiking","family":"Vega-Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n","family":"Fiestas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washington","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor J.","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.12.039_bib0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(13)70075-4","article-title":"Childhood pneumonia in developing countries","volume":"1","author":"Izadnegahdar","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0010","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0020","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper \u2013 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2014.12.039_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/S1020-49892009000300011","article-title":"The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence","volume":"25","author":"Valenzuela","year":"2009","journal-title":"Rev Panam Salud Publica"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.12.039_bib0030","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1016\/j.vaccine.2013.05.030","article-title":"Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean","volume":"31","author":"Bahia","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0040","first-page":"CD004977","article-title":"Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age","author":"Lucero","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0045","series-title":"Aprueba la Norma T\u00e9cnica de Salud que establece el esquema nacional de vacunaci\u00f3n","author":"Ministerio de Salud, Peru","year":"2009"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0050","first-page":"CD001480","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","volume":"4","author":"Fortanier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0055","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1590\/S1726-46342011000300001","article-title":"Health economic evaluations: bringing together academia and policy","volume":"28","author":"Mezones-Holgu\u00edn","year":"2011","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0070","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.vaccine.2010.11.075","article-title":"Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative","volume":"29","author":"Jauregui","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.12.039_bib0075","doi-asserted-by":"crossref","first-page":"C12","DOI":"10.1016\/j.vaccine.2013.05.033","article-title":"Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience","volume":"31","author":"Toscano","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.12.039_bib0080","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.vaccine.2013.05.045","article-title":"TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination","volume":"31","author":"Clark","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0085","first-page":"s243","article-title":"Sistema de salud de Per\u00fa","volume":"53","author":"Alcalde-Rabanal","year":"2011","journal-title":"Salud P\u00fablica M\u00e9xico"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0090","series-title":"Global burden of disease 2004 update: weights for diseases and conditions","author":"World Health Organization (WHO)","year":"2004"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0095","series-title":"The global burden of disease 2000 project: aims, methods and data sources. Global Programme on Evidence for Health Policy Discussion Paper No. 36","author":"Murray","year":"2001"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0100","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.healthpol.2009.07.012","article-title":"Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations","volume":"93","author":"Weatherly","year":"2009","journal-title":"Health Policy"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0110","series-title":"World mortality report 2011","author":"United Nations, Department of Economic and Social Affairs","year":"2012"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0115","first-page":"170","article-title":"Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease","volume":"72","author":"Thanavala","year":"2011","journal-title":"Adv Otorhinolaryngol"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0120","first-page":"204","article-title":"Prevalence of serotypes of Streptococcus pneumoniae and other agents that cause acute otitis media in children in Latin America. A systematic review of the literature","volume":"109","author":"Barajas Viracach\u00e1","year":"2011","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0125","first-page":"516","article-title":"Perfil etiol\u00f3gico de la neumon\u00eda adquirida en la comunidad en ni\u00f1os de 2 a 59 meses en dos zonas ecol\u00f3gicamente distintas del Per\u00fa","volume":"108","author":"Padilla Ygreda","year":"2010","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00006454-199305000-00008","article-title":"Outcomes of bacterial meningitis in children: a meta-analysis","volume":"12","author":"Baraff","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0135","first-page":"010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Global Health"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/160.1.83","article-title":"Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study","volume":"160","author":"Teele","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jpeds.2007.11.008","article-title":"Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations","volume":"152","author":"Hortal","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0150","series-title":"Laboratorio de Infecciones Respiratorias agudas e Infecciones Intrahospitalarias, Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Vigilancia de Streptococcus pneumoniae y Haemophilus influenzae en ni\u00f1os menores de 5 a\u00f1os. Per\u00fa 2000\u20132009","year":"2010"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0155","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3855\/jidc.5855","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccines for preventing pneumonia in children under five years in Peru","volume":"15","author":"Mezones-Holguin","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0160","series-title":"Resoluci\u00f3n Ministerial N\u00b0070-2011. Aprueba la Norma T\u00e9cnica de Salud NTS N\u00b0080-MINSAJDGSP-V.02 que establece el esquema nacional de vacunaci\u00f3n","author":"Ministerio de Salud, Per\u00fa","year":"2011"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0165","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)60317-2","article-title":"Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data","volume":"373","author":"Clark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0170","series-title":"Encuesta demogr\u00e1fica y de Salud Familiar-ENDES, 2007\u20132013","author":"Instituto Nacional de Estad\u00edstica e Inform\u00e1tica","year":"2014"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0175","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0180","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ijporl.2011.05.014","article-title":"Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis","volume":"75","author":"Bardach","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0185","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0190","series-title":"La carga de morbilidad de la enfermedad","author":"Dagna","year":"2007"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0195","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.vaccine.2005.12.025","article-title":"Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens","volume":"24","author":"Mahon","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0200","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.vaccine.2011.04.111","article-title":"Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina","volume":"29","author":"Urue\u00f1a","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S1020-49892010000800008","article-title":"Invasive pneumococcal diseases among hospitalized children in Lima, Peru","volume":"28","author":"Ochoa","year":"2010","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2334-12-124","article-title":"Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990\u20132010","volume":"12","author":"Casta\u00f1eda","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QCO.0b013e328352f727","article-title":"Vaccination and herd immunity: what more do we know?","volume":"25","author":"Rashid","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0220","series-title":"Metodolog\u00eda del costeo estandar","author":"Escobedo","year":"2007"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0225","series-title":"Direcci\u00f3n General de Medicamentos Insumos y Drogas. Observatorio de Productos Farmace\u00faticos: Sistema Nacional de Informaci\u00f3n de Precios","year":"2012"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0230","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0240","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO Guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/sti.2007.028043","article-title":"Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance","volume":"84","author":"Postma","year":"2008","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erv.13.36","article-title":"Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples","volume":"12","author":"Postma","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","article-title":"Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0260","series-title":"Constituci\u00f3n pol\u00edtica del Per\u00fa 1993: sumillas, reformas constitucionales, \u00edndice anal\u00edtico","author":"Arroyo","year":"2007"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0265","series-title":"The international covenant on economic, social, and cultural rights: a perspective on its development","author":"Craven","year":"1998"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-7547-11-21","article-title":"A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries","volume":"11","author":"Mart\u00ed","year":"2013","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0275","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S1020-49892008001100002","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis","volume":"24","author":"Sinha","year":"2008","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0280","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.vaccine.2009.12.070","article-title":"Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina","volume":"28","author":"Giglio","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/S1020-49892010000800004","article-title":"Cost-effectiveness of universal pneumococcal vaccination in Uruguay","volume":"28","author":"Giachetto Larraz","year":"2010","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0290","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1590\/S1020-49892009001200007","article-title":"Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil","volume":"26","author":"Vespa","year":"2009","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jech.2010.111880","article-title":"Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil","volume":"66","author":"Sartori","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinthera.2012.12.006","article-title":"Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden","volume":"35","author":"Klok","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jinf.2011.10.015","article-title":"Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands","volume":"64","author":"Strutton","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0310","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2334-10-260","article-title":"Economic evaluation of pneumococcal conjugate vaccination in The Gambia","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2334-12-101","article-title":"Cost-effectiveness of 2+1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada","volume":"12","author":"Earnshaw","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0320","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jval.2011.05.025","article-title":"Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines","volume":"14","author":"Muci\u00f1o-Ortega","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0325","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1472-6963-12-386","article-title":"Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model","volume":"12","author":"Bak\u0131r","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0330","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1016\/j.vaccine.2011.09.025","article-title":"Economic evaluation of second generation pneumococcal conjugate vaccines in Norway","volume":"29","author":"Robberstad","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0335","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1741-7015-9-53","article-title":"Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools","volume":"9","author":"Chaiyakunapruk","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0340","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1186\/1471-2458-13-1025","article-title":"Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru","volume":"13","author":"Gomez","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0345","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1016\/j.vaccine.2011.08.050","article-title":"The potential cost-effectiveness of infant pneumococcal vaccines in Australia","volume":"29","author":"Newall","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11589240-000000000-00000","article-title":"Health economic and infectious disease modelling: a guide to merging streams","volume":"29","author":"Anonychuk","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2014.12.039_bib0355","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jval.2011.11.013","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach","volume":"15","author":"Wu","year":"2012","journal-title":"Value Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14016922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:28Z","timestamp":1759400488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14016922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":71,"alternative-id":["S0264410X14016922"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}